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1. INTRODUCTION {#jmv25735-sec-0010}
===============

Since December 2019, the epidemic of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infectious pneumonia in Wuhan, China. The Chinese government and researchers have taken rapid measures to control the epidemic.[^1^](#jmv25735-bib-0001){ref-type="ref"} On January 30 2020, WHO declared that the epidemic of SARS‐CoV‐2 was a public health emergency of international concern (PHEIC). At present, the number of patients with SARS‐CoV‐2 infection is still rising, and its harm to human beings has exceeded the outbreak of severe acute respiratory syndrome (SARS) in China, 2002.[^2^](#jmv25735-bib-0002){ref-type="ref"} The clinical characteristics and the case fatality rate after SARS‐CoV‐2 infection have always been concerned by people, and it is also the focus of medical workers\' research at present. However, due to the different design of different clinical studies and insufficient sample size, the conclusions of the published studies were different. To acquire more accurate conclusions on the clinical characteristics and mortality of patients with SARS‐CoV‐2 infection, we searched the relevant literatures and carried out single‐arm meta‐analysis.[^3^](#jmv25735-bib-0003){ref-type="ref"} Our findings provide important guidance for current clinical work on the prevention and treatment of SARS‐CoV‐2 infection.

2. MATERIAL AND METHODS {#jmv25735-sec-0020}
=======================

2.1. Search strategy {#jmv25735-sec-0030}
--------------------

Three popular medical databases including PubMed, Cochrane Library, and Embase databases were searched for related literature, using the following keywords: "2019‐nCoV," "Coronavirus," "COVID‐19," "SARS‐CoV‐2," and "Wuhan Coronavirus." Articles reviewed were dated up to February 24, 2020. In this meta‐analysis, there was no language restriction. Only available data from published articles were collected. Data from unpublished papers were not included.

2.2. The inclusive and exclusive criteria {#jmv25735-sec-0040}
-----------------------------------------

### 2.2.1. Inclusive criteria {#jmv25735-sec-0050}

Studies that include randomized controlled trials, nonrandomized controlled trials, case‐control studies, cohort studies, cross‐sectional studies, and also case reports on the clinical characteristics of patients with SARS‐CoV‐2 infection. Clinical characteristics of patients with SARS‐CoV‐2 infection include fever (temperature ≥ 37.3°C), cough, muscle soreness or fatigue, acute respiratory distress syndrome (ARDS), abnormal chest computer tomography (CT) detection, patients in critical condition (severe cases are those who need to be sent to the intensive care unit (ICU) for treatment), as well as death due to SARS‐CoV‐2 infection.

### 2.2.2. Exclusive criteria {#jmv25735-sec-0060}

Articles were published repeatedly; studies did not include the research indicators needed for meta‐analysis; research data were missing.

2.3. Data extraction and paper quality evaluation {#jmv25735-sec-0070}
-------------------------------------------------

First of all, we screened the literature according to the literature abstract, excluding the articles that obviously do not meet the inclusive criteria, and then read the full article for rescreening. If any disagreement on the choice of the literature exists, a third evaluator will join to make the decision. All included literature were evaluated using the Newcastle‐Ottawa Scale (NOS).[^4^](#jmv25735-bib-0004){ref-type="ref"} The highest quality of the literature was 9 stars and the lowest 0 stars.

2.4. Statistical analysis {#jmv25735-sec-0080}
-------------------------

The statistical software Stata version 12.0 was used to carry out the single‐arm meta‐analysis. In order to reduce the influence of heterogeneity between the included studies on final conclusion, we used the random effects model for meta‐analysis. Original data included in the literature were first transformed by double arcsine method to make them conform to the normal distribution and then analyzed in Stata. The initial conclusion obtained by meta‐analysis was then restored using formula (*P* = (sin(tp/2))^2^) to reach final conclusion. To objectively evaluate the publication bias of the included literature, the Egger test with *P* \< .05 as the existence of publication bias was performed, the values larger than which were considered as no publication bias.

3. RESULTS {#jmv25735-sec-0090}
==========

3.1. Literature inclusion {#jmv25735-sec-0100}
-------------------------

A total of 284 articles were retrieved, among which 39 papers were removed due to repeated retrieval, 212 papers were removed after reading abstracts, and 23 were eliminated after reading the full text. At the end, a total of 10 articles[^5^](#jmv25735-bib-0005){ref-type="ref"}, [^6^](#jmv25735-bib-0006){ref-type="ref"}, [^7^](#jmv25735-bib-0007){ref-type="ref"}, [^8^](#jmv25735-bib-0008){ref-type="ref"}, [^9^](#jmv25735-bib-0009){ref-type="ref"}, [^10^](#jmv25735-bib-0010){ref-type="ref"}, [^11^](#jmv25735-bib-0011){ref-type="ref"}, [^12^](#jmv25735-bib-0012){ref-type="ref"}, [^13^](#jmv25735-bib-0013){ref-type="ref"}, [^14^](#jmv25735-bib-0014){ref-type="ref"} were included in this meta‐analysis, including data from 50 466 patients. The specific operation flow is shown in Figure [1](#jmv25735-fig-0001){ref-type="fig"}. The characteristics of the literature are shown in Table [1](#jmv25735-tbl-0001){ref-type="table"}.

![PRISMA flow diagram](JMV-9999-na-g001){#jmv25735-fig-0001}

###### 

The characteristics of the literature

  First author                                           Year                            Country   Follow‐up (days)   No. patients   Sex            Average age   Research type         Literature quality   Clinical symptom
  ------------------------------------------------------ ------------------------------- --------- ------------------ -------------- -------------- ------------- --------------------- -------------------- -------------------------------
  Huang et al[^5^](#jmv25735-bib-0005){ref-type="ref"}   2020                            China     18                 41             Male: 30       49            Retrospective study   7                    Fever
  ARDS                                                                                                                                                                                                       
  Muscle soreness or fatigue                                                                                                                                                                                 
  Cough                                                                                                                                                                                                      
  Abnormal chest CT                                                                                                                                                                                          
  Female: 11                                             Patient in critical condition                                                                                                                       
  Death of patient                                                                                                                                                                                           
  Wang et al[^6^](#jmv25735-bib-0006){ref-type="ref"}    2020                            China     34                 138            Male: 75       56            Retrospective study   7                    Fever
  ARDS                                                                                                                                                                                                       
  Muscle soreness or fatigue                                                                                                                                                                                 
  Cough                                                                                                                                                                                                      
  Abnormal chest CT                                                                                                                                                                                          
  Patient in critical condition                                                                                                                                                                              
  Female: 63                                             Death of patient                                                                                                                                    
  Chen et al[^7^](#jmv25735-bib-0007){ref-type="ref"}    2020                            China     25                 99             Male: 67       55.5          Retrospective study   6                    Fever
  ARDS                                                                                                                                                                                                       
  Muscle soreness or fatigue                                                                                                                                                                                 
  Female: 32                                             Cough                                                                                                                                               
  Abnormal chest CT                                                                                                                                                                                          
  Death of patient                                                                                                                                                                                           
  Guan W‐j[^8^](#jmv25735-bib-0008){ref-type="ref"}      2020                            China     28                 1099           Male: 640      47            Retrospective study   8                    Fever
  ARDS                                                                                                                                                                                                       
  Muscle soreness or fatigue                                                                                                                                                                                 
  Female: 459                                            Cough                                                                                                                                               
  Abnormal chest CT                                                                                                                                                                                          
  Patient in critical condition                                                                                                                                                                              
  Death of patient                                                                                                                                                                                           
  Chen et al[^9^](#jmv25735-bib-0009){ref-type="ref"}    2020                            China     15                 29             Male: 21       56            Retrospective study   6                    Fever
  Muscle soreness or fatigue                                                                                                                                                                                 
  Cough                                                                                                                                                                                                      
  Patient in critical condition                                                                                                                                                                              
  Death of patient                                                                                                                                                                                           
  Female: 8                                                                                                                                                                                                  
  Sun et al[^10^](#jmv25735-bib-0010){ref-type="ref"}    2020                            America   42                 288            Male: 182      44            Retrospective study   5                    Death of patient
  Female: 106                                                                                                                                                                                                
  Yang et al[^11^](#jmv25735-bib-0011){ref-type="ref"}   2020                            China     51                 4021           Male: 2211     49            Retrospective study   5                    Patient in critical condition
  Female:1810                                            Death of patient                                                                                                                                    
  Li et al[^12^](#jmv25735-bib-0012){ref-type="ref"}     2020                            China     21                 17             Male: 9        45            Retrospective study   6                    Fever
  Female: 8                                              Muscle soreness or fatigue                                                                                                                          
  Cough                                                                                                                                                                                                      
  Abnormal chest CT                                                                                                                                                                                          
  China CDC[^13^](#jmv25735-bib-0013){ref-type="ref"}    2020                            China     43                 44 672         Male: 22 981   --            Retrospective study   6                    Patient in critical condition
  Female: 21 691                                         Death of patient                                                                                                                                    
  Xu[^14^](#jmv25735-bib-0014){ref-type="ref"}           2020                            China     16                 62             Male: 36       41            Retrospective study   6                    Fever
  Muscle soreness or fatigue                                                                                                                                                                                 
  Cough                                                                                                                                                                                                      
  Abnormal chest CT                                                                                                                                                                                          
  Patient in critical condition                                                                                                                                                                              
  Death of patient                                                                                                                                                                                           
  Female: 26                                                                                                                                                                                                 

Abbreviation: China CDC, Chinese Center for Disease Control and Prevention.

John Wiley & Sons, Ltd.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

3.2. Meta‐analysis results {#jmv25735-sec-0110}
--------------------------

Through Meta‐analysis, we found that among all the clinical characteristics of patients with SARS‐CoV‐2 infection, the incidence of fever was 0.891 (95% CI: 0.818, 0.945), the incidence of cough was 0.722 (95% CI: 0.657, 0.782), and the incidence of muscle soreness or fatigue was 0.425 (95% CI: 0.213, 0.652). The incidence of acute respiratory distress syndrome (ARDS) was 0.148 (95% CI: 0.046, 0.296), the incidence of abnormal chest computer tomography (CT) was 0.966 (95% CI: 0.921, 0.993), the percentage of severe cases in all infected cases was 0.181 (95% CI: 0.127, 0.243), and the case fatality rate of patients with SARS‐CoV‐2 infection was 0.043 (95% CI: 0.027, 0.061). Detailed results of Meta‐analysis are shown in Table [2](#jmv25735-tbl-0002){ref-type="table"}.

###### 

Meta‐analysis results

  Clinical symptom                Results of meta‐analysis    Adjusted results
  ------------------------------- --------------------------- ------------------------------
  Fever                           2.47(95% *CI*: 2.26,2.67)   0.891(95% *CI*: 0.818,0.945)
  Cough                           2.03(95% *CI*: 1.89,2.17)   0.722(95% *CI*: 0.657,0.782)
  Muscle soreness or fatigue      1.42(95% *CI*: 0.96,1.88)   0.425(95% *CI*: 0.213,0.652)
  ARDS                            0.79(95% *CI*: 0.43,1.15)   0.148(95% *CI*: 0.046,0.296)
  Abnormal chest CT               2.77(95% *CI*: 2.57,2.97)   0.966(95% *CI*: 0.921,0.993)
  Patient in critical condition   0.88(95% *CI*: 0.73,1.03)   0.181(95% *CI*: 0.127,0.243)
  Death of patient                0.42(95% *CI*: 0.33,0.50)   0.043(95% *CI*: 0.027,0.061)

Abbreviations: ARDS, acute respiratory distress syndrome; CI, confidence interval; CT, computer tomography.

John Wiley & Sons, Ltd.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

3.3. Publication bias detection {#jmv25735-sec-0120}
-------------------------------

The results of the Egger test are shown in Table [3](#jmv25735-tbl-0003){ref-type="table"}. There was a publication bias in the meta‐analysis of the ARDS group (*P* = .008).

###### 

Results of Egger test

  Groups   Fever group   Cough group   Muscle soreness or fatigue group   ARDS group   Abnormal chest CT group   Severe cases group   Death cases group
  -------- ------------- ------------- ---------------------------------- ------------ ------------------------- -------------------- -------------------
  *P*      .866          .278          .090                               .008         .908                      .826                 .258

Abbreviations: ARDS, acute respiratory distress syndrome; CT, computer tomography.

John Wiley & Sons, Ltd.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

4. DISCUSSION {#jmv25735-sec-0130}
=============

SARS‐CoV‐2 is one type of coronaviruses that belong to the β‐coronavirus cluster. It causes the third kind of zoonotic coronavirus disease after SARS and Middle East respiratory syndrome (MERS). Wei Ji et al[^15^](#jmv25735-bib-0015){ref-type="ref"} found that SARS‐CoV‐2 seemed to be a recombinant virus between bat coronavirus and coronavirus of another unknown origin. Xiao et al[^16^](#jmv25735-bib-0016){ref-type="ref"} confirmed that Malayan pangolins were the most likely intermediate host of SARS‐CoV‐2. The research of Benvenuto et al[^17^](#jmv25735-bib-0017){ref-type="ref"} found that SARS‐CoV‐2 was only closely related to the coronavirus isolated from the chrysanthemum‐headed bat in 2015. Their research suggests that bats may be the reservoir host for SARS‐CoV‐2. According to the research by Zhou et al[^18^](#jmv25735-bib-0018){ref-type="ref"} and Wu et al,[^19^](#jmv25735-bib-0019){ref-type="ref"} it was found that the sequence homology between SARS‐CoV‐2 and SARS‐CoV was 79.5%. The homology between SARS‐CoV‐2 and bat coronavirus at the genetic level was 96%. Therefore, very likely it can be confirmed that SARS‐CoV‐2 comes from bats.

According to the results of meta‐analysis, we find that the incidence of fever was 89.1%, the incidence of cough was 72.2%, and the incidence of muscle soreness or fatigue was 42.5%. The incidence of ARDS was 14.8%, the incidence of abnormal CT was 96.6%, the percentage of severe cases in all infected cases was 18.1%, and the case fatality rate of patients with SARS‐CoV‐2 infection was 4.3%. Weijie Guan et al.[^8^](#jmv25735-bib-0008){ref-type="ref"} found that the common patterns on chest CT were ground‐glass opacity and bilateral patchy shadowing in patients with SARS‐CoV‐2 infection. Chaolin Huang et al.[^5^](#jmv25735-bib-0005){ref-type="ref"} found that the typical chest CT images of severe cases were bilateral multiple lobular and subsegmental areas of consolidation. In addition, by reading the included literature,[^5^](#jmv25735-bib-0005){ref-type="ref"}, [^6^](#jmv25735-bib-0006){ref-type="ref"}, [^7^](#jmv25735-bib-0007){ref-type="ref"}, [^8^](#jmv25735-bib-0008){ref-type="ref"}, [^9^](#jmv25735-bib-0009){ref-type="ref"}, [^10^](#jmv25735-bib-0010){ref-type="ref"}, [^11^](#jmv25735-bib-0011){ref-type="ref"}, [^12^](#jmv25735-bib-0012){ref-type="ref"}, [^13^](#jmv25735-bib-0013){ref-type="ref"}, [^14^](#jmv25735-bib-0014){ref-type="ref"} we found that diarrhea, hemoptysis, headache, sore throat, shock, and other symptoms are rare.

At present, the Chinese government has announced that the case fatality rate of patients with SARS‐CoV‐2 infection in China is 3.8%, which is lower than that of another two widely contagious zoonotic coronavirus diseases, SARS and MERS. Infection mortality rates of SARS and MERS are 9.6%[^20^](#jmv25735-bib-0020){ref-type="ref"} and 35%,[^21^](#jmv25735-bib-0021){ref-type="ref"} respectively. Since the case fatality rate of patients with SARS‐CoV‐2 infection is low, a large number of patients with SARS‐CoV‐2 infection will be cured. Sheng et al[^22^](#jmv25735-bib-0022){ref-type="ref"} have shown that viral infection could increase the risk of pulmonary fibrosis. Xie et al[^23^](#jmv25735-bib-0023){ref-type="ref"} found that 45% of patients showed signs of pulmonary fibrosis within 1 month after being infected with SARS‐CoV. Hui[^24^](#jmv25735-bib-0024){ref-type="ref"} revealed that 36% and 30% of patients infected with SARS‐CoV developed pulmonary fibrosis 3 and 6 months after infection. These studies consistently suggest that pulmonary fibrosis will become one of the serious complications in patients with SARS‐CoV‐2 infection. How to prevent and reduce the occurrence of pulmonary fibrosis in patients with SARS‐CoV‐2 infection are urgent problems for medical workers in the treatment of SARS‐CoV‐2.

Zhao et al[^25^](#jmv25735-bib-0025){ref-type="ref"} found that angiotensin‐converting enzyme 2 (ACE2) was the receptor of SARS‐CoV‐2. In normal lung tissue, ACE2 is mainly expressed by type I and type II alveolar epithelial cells. It was reported that 83% of II type alveolar cells expressed ACE2. Therefore, SARS‐CoV‐2 infection causes damages to most II type alveolar cells. In addition, the use of mechanical ventilation in the treatment of patients with SARS‐CoV‐2 infection can also aggravate the injury of alveolar cells. After alveolar cell injury, transforming growth factor‐β (TGF‐ β) released in tissue promotes lung repair. Virus infection often leads to excessive activation of TGF‐β pathway, which leads to the occurrence of pulmonary fibrosis.

Based on the mechanism of pulmonary fibrosis after virus infection, we can formulate corresponding prevention and treatment proposals. The first is the treatment of SARS‐CoV‐2 infection. At present, a variety of drugs have been found to inhibit SARS‐CoV‐2. Holshue et al[^26^](#jmv25735-bib-0026){ref-type="ref"} achieved remarkable results in the treatment of patients with SARS‐CoV‐2 infection with remdesivir. This drug is currently in clinical trials. Second, it is necessary to inhibit the inflammatory reaction and reduce exudation. In this direction, antibiotics not only have traditional antibacterial effects but also have immunomodulatory and anti‐inflammatory properties.[^27^](#jmv25735-bib-0027){ref-type="ref"} Macrolide antibiotics such as clarithromycin, azithromycin, and erythromycin prevent the production of proinflammatory cytokines and immune mediators.[^28^](#jmv25735-bib-0028){ref-type="ref"} The third is to inhibit the fibrogenic effect of TGF‐β. Luo et al[^29^](#jmv25735-bib-0029){ref-type="ref"} found that arsenic trioxide could inhibit the signal transduction of TGF‐β and play a role in antifibrosis. The fourth is the rational use of ventilator to avoid unnecessary lung damages. In addition, pirfenidone and nintedanib as drugs for the treatment of idiopathic pulmonary fibrosis can also be used to prevent and treat pulmonary fibrosis in patients with SARS‐CoV‐2 infection.[^30^](#jmv25735-bib-0030){ref-type="ref"}

In all, a total of 10 articles were covered in the meta‐analysis, including 50 466 patients with SARS‐CoV‐2 infection. By far, it is the first meta‐analysis with the largest sample size. The quality of the literature included in this study is high, the analysis is rigorous, and the conclusions drawn by the study are highly credible. However, this meta‐analysis also has some limitations: (a) all studies included in this meta‐analysis are retrospective studies with large heterogeneity; (b) most patients in our meta‐analysis are Chinese, and we aimed to use the conclusions of this study to predict patients in general, including other countries and races; (c) there was publication bias in the meta‐analysis of the ARDS group. The analytical conclusion of the ARDS group may be influenced by publication bias; and (d) the study subjects were inpatients who have been diagnosed with SARS‐CoV‐2 infection. So, the incidence of severe pneumonia or the fatality rate in the total population infected with SARS‐CoV‐2 would be much lower than the results shown in this study.

Therefore, based on the above‐mentioned limitations, the conclusions of this meta‐analysis still need to be verified by more relevant studies with more careful design, more rigorous execution, and larger sample size.
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